The U.S.Food and Drug Administration announced it is requesting public information on gluten labeling and cross-contamination in packaged foods, marking an initial effort to enhance transparency for consumers with celiac disease and food allergies ... .
ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing in patients with ulcerative colitis and Crohn's disease....
The Food and Drug Administration is weighing whether to allow new advertising messages about Zyn, a type of nicotine pouch that's growing in popularity ... .